Publications by authors named "Shaoding Lin"

Claim this Profile
C
Clinical Outcomes of Patients With Advanced ALK-Rearranged Lung Squamous Cell Carcinoma Treated With ALK Tyrosine Kinase Inhibitors.
Yuanze Sun, Dan Yang, Zhe Huang, Huan Yan, Liang Zeng, Ling Peng, Shaoding Lin

Clin Lung Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphocyte subset-based non-invasive biomarker predicts immunochemotherapy efficacy in EGFR-TKI-pretreated EGFR-mutated NSCLC.
Lianxi Song, Liang Zeng, Qinqin Xu, Yizhi Li, Wenhuan Guo, Shaoding Lin, Lin Zhang

iScience· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential utility of albumin-bilirubin and body mass index-based logistic model to predict survival outcome in non-small cell lung cancer with liver metastasis treated with immune checkpoint inhibitors.
Lianxi Song, Qinqin Xu, Ting Zhong, Wenhuan Guo, Shaoding Lin, Lin Zhang

Chin Med J (Engl)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Baseline Molecular Factors Associated With the Risk of Central Nervous System Progression Among Alectinib-Treated Patients With ALK-Positive NSCLC.
Lianxi Song, Huan Yan, Qinqin Xu, Chunhua Zhou, Juan Liang, Shaoding Lin

JTO Clin Res Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a prognostic nomogram for advanced non-small cell lung cancer using clinical characteristics.
Haoyue Qin, Zhe Huang, Huan Yan, Lianxi Song, Liang Zeng, Shaoding Lin, Lin Zhang

iScience· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective study.
Zhe Huang, Yuda Zhang, Qinqin Xu, Lianxi Song, Yizhi Li, Shaoding Lin, Lin Zhang

Lung Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human phase I study of BEBT-109 in previously treated EGFR exon 20 insertion-mutated advanced non-small cell lung cancer.
Liang Zeng, Lianxi Song, Li Liu, Fang Wu, Qinqin Xu, Shaoding Lin, Lin Zhang

Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China.
Huan Yan, Lianxi Song, Yizhi Li, Qinqin Xu, Wenhuan Guo, Shaoding Lin, Lin Zhang

Cancer Immunol Immunother· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic cytokines signature predicts survival outcome from severe Immune-related hepatitis with PD-1/PD-L1 blockade in lung cancer.
Liang Zeng, Yuling Zhou, Qinqin Xu, Zhe Huang, Lianxi Song, Shaoding Lin

Lung Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With -Rearranged Advanced Lung Adenocarcinoma: A Multicenter, Retrospective Cohort Study.
Zhe Huang, Huan Yan, Liang Zeng, Qinqin Xu, Wenhuan Guo, Shaoding Lin, Lin Zhang

JCO Precis Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis